Accelerometry reveals differences in gait variability between patients with multiple sclerosis and healthy controls

Jessie M. Huisinga, Martina Mancini, Rebecca J. St. George, Fay B. Horak

Research output: Contribution to journalArticlepeer-review

79 Scopus citations

Abstract

Variability of movement reflects important information for the maintenance of the health of the system. For pathological populations, changes in variability during gait signal the presence of abnormal motor control strategies. For persons with multiple sclerosis (PwMS), extensive gait problems have been reported including changes in gait variability. While previous studies have focused on footfall variability, the present study used accelerometers on the trunk to measure variability during walking. Thus, the purpose of this study was to examine the variability of the acceleration pattern of the upper and lower trunk in PwMS compared to healthy controls. We extracted linear and nonlinear measures of gait variability from 30 s of steady state walking for 15 PwMS and 15 age-matched healthy controls. PwMS had altered variability compared to controls with greater Lyapunov exponent in the ML (p < 0.001) and AP (p < 0.001) directions, and greater frequency dispersion in the ML direction (p = 0.034). PwMS also demonstrated greater mean velocity in the ML direction (p = 0.045) and lower root mean square of acceleration in the AP direction (p = 0.040). These findings indicate that PwMS have altered structure of variability of the trunk during gait compared to healthy controls and agree with previous findings related to changes in gait variability in PwMS.

Original languageEnglish (US)
Pages (from-to)1670-1679
Number of pages10
JournalAnnals of Biomedical Engineering
Volume41
Issue number8
DOIs
StatePublished - Aug 2013

Keywords

  • Lyapunov exponent
  • Nonlinear
  • Steady state
  • Trunk

ASJC Scopus subject areas

  • Biomedical Engineering

Fingerprint

Dive into the research topics of 'Accelerometry reveals differences in gait variability between patients with multiple sclerosis and healthy controls'. Together they form a unique fingerprint.

Cite this